Most ankle injuries can be treated conservatively with Rest, Ice, Compression bandage and Elevation. When ligament injuries are complete and fail to heal with these methods, Surgery may be indicated. Patients with repeated episodes of ankle giving way, will need Surgery.
We are using a free tendon graft to recreate the ATFL and CFL ligaments, to achieve reproducible, rigid, anatomic reconstruction for patients with continued ligament laxity.
3 days hospitalisation and 3 month rehab will take you back to complete stability and return to sports activities.
Adverse Events Due to IV Bisphosphonates for Paediatric Osteoporosis Are Usually Mild, Manageable
Bisphosphonates are safe to administer intravenously to children who have developed secondary osteoporosis, according to a study presented here at the 2018 Annual Meeting of the Pediatric Academic Societies (PAS). The researchers looked at data from patients aged younger than 21 years who received IV pamidronate or IV zoledronic acid between 2010 and 2017. Acute adverse events occurred in 5.5% of infusions and were more frequent in secondary osteoporosis and following the first infusion.
Another toxicity observed was hypocalcaemia, which developed in 7.1% of infusions and was linked significantly with the use of zoledronic acid. Hypocalcaemia that did develop was mild for the most part and when needed, managed with intravenous calcium. He said that patients will often prefer zoledronic acid because it requires fewer infusions than pamidronate as well as shorter duration of infusions. The researchers found improved measures in trabecular bone mineral density but did not find improvements in cortical bone density. There were no cases of osteonecrosis of the jaw or atypical femoral fracture.
The data suggest a need for greater vigilance of toxicities in paediatric patients with secondary osteoporosis being treated with IV bisphosphonates. However, “intravenous bisphosphonates can be safely used in paediatric patients with osteoporosis,” the authors concluded.